Key Highlights
- CoreWeave announced an $8.5 billion delayed draw term loan facility dedicated to AI infrastructure development.
- Shares climbed 12% in Tuesday’s session, pushing the stock back into positive territory year-to-date.
- This marks the inaugural investment-grade rated delayed draw term loan supported by high-performance computing assets and customer agreements.
- Combined equity and debt financing raised over the last 12 months has reached approximately $28 billion.
- Stifel maintained its Hold recommendation with a $110 target price, citing leverage concerns while recognizing the company’s robust $66.8 billion contract backlog.
CoreWeave delivered an impressive single-session performance Tuesday, rallying 12% following the announcement of an $8.5 billion financing package designed to accelerate its artificial intelligence infrastructure expansion plans.
CoreWeave, Inc. Class A Common Stock, CRWV
The financing arrangement takes the form of a delayed draw term loan facility, which allows CoreWeave to access capital progressively rather than in a single lump sum. The company can immediately tap up to $7.5 billion, with another $1 billion becoming available once certain asset performance benchmarks are met. The agreement extends through March 2032.
The significance of this transaction lies in its credit ratings. Both Moody’s and DBRS granted investment-grade status—A3 and A (low) respectively—representing the first time a delayed draw term loan secured by high-performance computing infrastructure and customer commitments has received such favorable ratings.
The loan package combines both floating and fixed-rate components, with the variable portion priced at the secured overnight financing rate plus 225 basis points, and the fixed segment carrying roughly 5.9% interest. Chief Development Officer Brannin McBee emphasized that this structure reduces the company’s weighted average cost of capital—a strategic imperative for CoreWeave.
“We’re competing with some of the largest companies on the planet that have the best cost of capital,” McBee told Barron’s. “The only way to be at scale and growing alongside these massive businesses is to stand up financing structures like this.”
This consideration is particularly relevant given CoreWeave’s fourth quarter 2025 results, which showed that 25% of revenue was allocated to servicing interest expenses on approximately $30 billion in outstanding debt and lease obligations. Achieving investment-grade borrowing rates represents both a validation milestone and an operational requirement.
Financing Blitz Totals $28 Billion Over Past Year
This latest transaction brings CoreWeave’s combined equity and debt capital commitments secured during the trailing 12-month period to roughly $28 billion. For a recently listed public company, this represents an extraordinarily aggressive capital accumulation pace.
Tuesday’s 12% surge reversed the stock’s year-to-date losses and pushed shares into positive territory for 2026. The timing proved fortuitous for ARK Invest, managed by Cathie Wood, which accumulated over 41,000 CRWV shares on Monday—immediately preceding Tuesday’s announcement.
The momentum continued Wednesday morning, with shares advancing an additional 1.5% in pre-market activity, suggesting sustained investor interest beyond the initial reaction.
Wall Street Perspective: Supportive Yet Reserved
Following the financing announcement, Stifel’s Ruben Roy reaffirmed his Hold rating alongside a $110 price objective. Roy acknowledged that the capital raise reinforces confidence in CoreWeave’s substantial $66.8 billion revenue pipeline and the stability of its multi-year customer agreements.
However, Roy declined to upgrade the stock, indicating he prefers to observe near-term operational execution—particularly progress on next-generation data center deployment and profitability enhancement—before adopting a more constructive stance.
Broader Wall Street sentiment mirrors this measured approach. The consensus rating for CRWV stands at Hold, derived from 13 Buy recommendations, 9 Hold ratings, and 1 Sell opinion compiled over the most recent three-month period. The mean analyst price target of $112.81 suggests approximately 45% potential appreciation from current trading levels.
